Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16

Journal of the National Cancer Institute
Daniel P PetrylakE David Crawford

Abstract

The identification of surrogate endpoints that can replace true outcome endpoints is crucial to the rapid evaluation of new cancer drugs. Retrospective analyses of phase II and III trials in metastatic androgen-independent prostate cancer have shown associations between declines in serum prostate-specific antigen (PSA) levels and survival. We evaluated PSA changes as potential surrogate markers for survival by using data from a clinical trial. Men with androgen-independent prostate cancer were randomly assigned to either docetaxel/estramustine (D/E) or mitoxantrone/prednisone (M/P) treatment on Southwest Oncology Group Protocol 99-16. Of 674 eligible patients, 551 had a baseline PSA measurement and at least one PSA measurement during the first 3 months on protocol. PSA level declines of 5%-90% and PSA velocity at 1, 2, and 3 months were tested for surrogacy by using three statistical criteria: Prentice's criteria, the proportion of treatment effect explained, and the proportion of variation explained. All statistical tests were two-sided. Three-month PSA level declines of 20%-40%, a 2-month PSA decline of 30%, and PSA velocity at 2 and 3 months met all three surrogacy criteria. For example, a 3-month PSA decline of at least 30%...Continue Reading

References

Jan 30, 1992·Statistics in Medicine·L S FreedmanA Schatzkin
Apr 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K KellyS D Fossa
Dec 30, 1993·Statistics in Medicine·M Schemper
Jul 15, 1997·Statistics in Medicine·D Y LinV De Gruttola
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D C SmithK J Pienta
Oct 8, 1998·The New England Journal of Medicine·M A EisenbergerB A Lowe
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G J BubleyG Wilding
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E J SmallM Eisenberger
Jan 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I ScherHoward R Soule
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Oct 8, 2005·Oncology·Stefanie Schier, Nicholas A Wright

❮ Previous
Next ❯

Citations

Sep 4, 2009·Nature Reviews. Urology·Gerhardt Attard, Johann S de Bono
Jul 15, 2009·Prostate Cancer and Prostatic Diseases·P F Mulders, J A Schalken
Jan 13, 2010·Prostate Cancer and Prostatic Diseases·A J Armstrong, D J George
Aug 12, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CollocaA Venturino
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J MichelsK N Chi
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G SonpavdeT E Hutson
Mar 31, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M D Galsky, N J Vogelzang
Sep 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J S de BonoD P Petrylak
Jun 27, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D Raghavan
Apr 20, 2006·Journal of the National Cancer Institute·Stuart G Baker
Feb 13, 2009·Journal of the National Cancer Institute·Michael E RayHoward M Sandler
Feb 13, 2009·Journal of the National Cancer Institute·Ross L Prentice
Feb 28, 2008·The Cancer Journal·Franklin L ChenDaniel J George
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan HalabiEric J Small
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maha HussainE David Crawford
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhardt AttardJohann S de Bono
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I ScherGlenn Heller
Jan 1, 2007·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Tomas Buchler, Stephen J Harland
May 27, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Sujith Kalmadi, Derek Raghavan
Mar 20, 2013·Chemotherapy Research and Practice·Stavros SfoungaristosPetros Perimenis
Jan 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R Leibowitz-AmitA M Joshua
Apr 26, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A GagnatJ Irani
Jul 21, 2012·Wiener klinische Wochenschrift·Michael RauchenwaldMichael Krainer
May 9, 2014·Molecular Diagnosis & Therapy·Giuseppe GallettiDavid M Nanus
Sep 10, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Edoardo FranciniGiandomenico Roviello
Aug 30, 2008·Wiener klinische Wochenschrift·Michael RauchenwaldMichael Krainer
Jul 23, 2013·Critical Reviews in Oncology/hematology·Enrique GallardoJoaquim Bellmunt
Feb 17, 2015·Biometrical Journal. Biometrische Zeitschrift·Marc BuyseTomasz Burzykowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Andrew J ArmstrongMario Eisenberger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Andrew J ArmstrongMario Eisenberger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Howard I ScherProstate Cancer Clinical Trials Working Group
© 2022 Meta ULC. All rights reserved